Chinese Journal of Cancer Research

, Volume 22, Issue 2, pp 87–92 | Cite as

Antioxidant enzymes and cancer

  • Md. Asaduzzaman Khan
  • Mousumi Tania
  • Dian-zheng Zhang
  • Han-chun ChenEmail author


Although oxidation is the most common biological and energy producing reaction, oxidative stress is harmful to cell, because the products of oxidation such as free radicals and peroxides damage the cellular components, causing several diseases. Damage in DNA is responsible for cancer formation and progression. However, several enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione S-transferase etc. act as antioxidants to influence oxidative stress. Polymorphisms in these enzymes are supposed to be associated with DNA damage and subsequently the individual’s risk of cancer susceptibility. This review article aims to further elucidate the relationship between antioxidant enzymes and cancers by summarizing the findings of some of the important study concerning expression levels and genetic polymorphisms of antioxidant enzymes in cancer patients.


Superoxide dismutase Catalase Glutathione peroxidase Glutathione-S-Transferase Cancer 




Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Champe PC, Harvey RA, Ferrier DR. Intermediary metabolism. Champe PC, Lippincott’s Illustrated Reviews: Biochemistry. 4th edition[M]. Lippincott Williams & Wilkins. Philadelphia, USA. 2007; p: 69–82, 148.Google Scholar
  2. [2]
    Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease[J]. Int J Biochem Cell Biol 2007; 39: 44–84.CrossRefPubMedGoogle Scholar
  3. [3]
    Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research[J]. J Nutr 2003; 133: 933S–40S.PubMedGoogle Scholar
  4. [4]
    Bagchi K, Puri S. Free radicals and antioxidants in health and disease[J]. Eastern Mediterranean Health Journal 1998; 4: 350–360.Google Scholar
  5. [5]
    Frederiks WM, Bosch KS, Hoeben KA, et al. Renal cell carcinoma and oxidative stress: The lack of peroxisomes[J]. Acta Histochem 2009; Jun 3 [Epub ahead of print]Google Scholar
  6. [6]
    Hussain SP, Raja K, Amstad PA, et al. Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: oxyradical overload diseases[J]. Proc Natl Acad Sci USA 2000; 97: 12770–12775.CrossRefPubMedGoogle Scholar
  7. [7]
    Gargouri B, Lassoued S, Ayadi W, et al. Lipid peroxidation and antioxidant system in the tumor and in the blood of patients with nasopharyngeal carcinoma[J]. Biol Trace Elem Res 2009; 132: 27–34.CrossRefGoogle Scholar
  8. [8]
    Kulbacka J, Saczko J, Chwiłkowska A. Oxidative stress in cells damage processes[J]. Pol Merkur Lekarski 2009; 27: 44–47.PubMedGoogle Scholar
  9. [9]
    Sengottuvelan M, Deeptha K, Nalini N. Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis[J]. Chem Biol Interact 2009; 181: 193–201.CrossRefPubMedGoogle Scholar
  10. [10]
    Elchuri S, Oberley TD, Qi W, et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life[J]. Oncogene 2005; 24: 367–380.CrossRefPubMedGoogle Scholar
  11. [11]
    Plymate SR, Haugk KH, Sprenger CC, et al. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1[J]. Oncogene 2003; 22: 1024–1034.CrossRefPubMedGoogle Scholar
  12. [12]
    Aggarwal S, Subberwal M, Kumar S, et al. Brain tumor and role of beta-carotene, a-tocopherol, superoxide dismutase and glutathione peroxidases[J]. J Cancer Res Ther 2006; 2: 24–27.CrossRefPubMedGoogle Scholar
  13. [13]
    de Haan JB, Cristiano F, Iannello R, et al. Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide[J]. Hum Mol Genet 1996; 5: 283–292.CrossRefPubMedGoogle Scholar
  14. [14]
    Chung-man Ho J, Zheng S, Comhair SA, et al. Differential expression of manganese superoxide dismutase and catalase in lung cancer[J]. Cancer Res 2001; 61: 8578–8585.PubMedGoogle Scholar
  15. [15]
    Okada F, Shionoya H, Kobayashi M. Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase[J]. Br J Cancer 2006; 94: 854–862.CrossRefPubMedGoogle Scholar
  16. [16]
    Er TK, Hou MF, Tsa EM, et al. Differential expression of manganese containing superoxide dismutase in patients with breast cancer in taiwan[J]. Ann Clin Lab Sci 2004; 34: 159–164.PubMedGoogle Scholar
  17. [17]
    Kacakci A, Aslan I, Toplan S, et al. Significance of the counteracting oxidative and antioxidative systems in the pathogenesis of laryngeal carcinoma[J]. J Otolaryngol Head Neck Surg 2009; 38: 172–177.PubMedGoogle Scholar
  18. [18]
    Mason EE, Chin TF, Li YW, et al. Cancer and human liver catalase[J]. Cancer Res 1960; 20: 1474–1481.PubMedGoogle Scholar
  19. [19]
    Falkson G, Dejager ME. Catalase activity in the epidermis of patients with advanced cancer[J]. Nature 1964; 202: 203–204.CrossRefPubMedGoogle Scholar
  20. [20]
    De Craemer D, Pauwels M, Hautekeete M, et al. Alterations of hepatocellular peroxisomes in patients with cancer. Catalase cytochemistry and morphometry [J]. Cancer 1993; 71: 3851–3858.CrossRefPubMedGoogle Scholar
  21. [21]
    Surapaneni KM, Sadagopan C. Status of Lipid peroxidation and antioxidant enzymes in patients with carcinoma of breast[J]. J Med Sci Res 2007; 1: 21–24.Google Scholar
  22. [22]
    Ahn J, Gammon MD, Santella RM, et al. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use[J]. Am J Epidemiol 2005; 162: 943–952.CrossRefPubMedGoogle Scholar
  23. [23]
    Yamamoto T, Sakaguchi N, Hachiya M, et al. Role of catalase in monocytic differentiation of U937 cells by TPA: hydrogen peroxide as a second messenger[J]. Leukemia 2009; 23: 761–769.CrossRefPubMedGoogle Scholar
  24. [24]
    Petit E, Courtin A, Kloosterboer HJ, et al. Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition[J]. J Steroid Biochem Mol Biol 2009; 115(3–5): 153–160.CrossRefPubMedGoogle Scholar
  25. [25]
    Mannervik B. The enzymes of glutathione metabolism: an overview[J]. Biochem Soc Trans 1987; 15: 717–718.PubMedGoogle Scholar
  26. [26]
    Meister A. Glutathione metabolism and its selective modification[J]. J Biol Chem 1988; 263: 17205–17208.PubMedGoogle Scholar
  27. [27]
    Moscow JA, Schmidt L, Ingram DT, et al. Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer[J]. Carcinogenesis 1994; 15: 2769–2773.CrossRefPubMedGoogle Scholar
  28. [28]
    Ratnasinghe D, Tangrea JA, Andersen MR, et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk[J]. Cancer Res 2000; 60: 6381–6383.PubMedGoogle Scholar
  29. [29]
    Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer loss of heterozygosity and allelic differences in the response to selenium[J]. Cancer Res 2003; 63: 3347–3351PubMedGoogle Scholar
  30. [30]
    Moscow JA, Morrow CS, He R, et al. Structure and function of the 5′-flanking sequence of the human cytosolic selenium-dependent glutathione peroxidase gene (hgpx1)[J]. J Biol Chem 1992; 267: 5949–5958.PubMedGoogle Scholar
  31. [31]
    Chada S, Whitney C, Newburger PE. Post-transcriptional regulation of glutathione peroxidase gene expression by selenium in the HL-60 human myeloid cell line[J]. Blood 1989; 74: 2535–2541.PubMedGoogle Scholar
  32. [32]
    Willett WC, Polk BF, Morris JS, et al. Prediagnostic serum selenium and risk of cancer[J]. Lancet 1983; 2: 130–134.CrossRefPubMedGoogle Scholar
  33. [33]
    Comstock GW, Alberg AJ, Huang HY, et al. The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity[J]. Cancer Epidemiol Biomarkers Prev 1997; 6: 907–916PubMedGoogle Scholar
  34. [34]
    Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer[J]. J Natl Cancer Inst 1998; 90: 1219–1224.CrossRefPubMedGoogle Scholar
  35. [35]
    Brooks JD, Metter EJ, Chan DW, et al. Plasma selenium level before diagnosis and the risk of prostate cancer development[J]. J Urol 2001; 166: 2034–2038.CrossRefPubMedGoogle Scholar
  36. [36]
    Leaver MJ, George SG. A piscine glutathione S-transferase which efficiently conjugates the end-products of lipid peroxidation[J]. Marine Environ Res 1998; 46: 71–74.CrossRefGoogle Scholar
  37. [37]
    Houlstone RS. Glutathione S-transferase M1 status and lung cancer risk: A meta-analysis[J]. Cancer Epidemiol Biomark Prev 1999; 8: 675–682.Google Scholar
  38. [38]
    Ambrosone CB, Coles BF, Freudenheim JL, et al. Glutathione-S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants[J]. J Nutr 1999; 129: 565S–568S.PubMedGoogle Scholar
  39. [39]
    Curran JE, Weinstein SR, Griffiths LR. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility[J]. Cancer Lett 2000; 153: 113–120.CrossRefPubMedGoogle Scholar
  40. [40]
    Smith RA, Curran JE, Weinstein SR, et al. Investigation of glutathione S-transferase zeta and the development of sporadic breast cancer[J]. Breast Cancer Res 2001; 3: 409–411.CrossRefPubMedGoogle Scholar
  41. [41]
    Park SK, Yoo KY, Lee SJ, et al. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk[J]. Pharmacogenetics 2000; 10: 301–309.CrossRefPubMedGoogle Scholar
  42. [42]
    Mao GE, Morris G, Lu QY, et al. Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer[J]. Cancer Detect Prev 2004; 28: 368–374.CrossRefPubMedGoogle Scholar
  43. [43]
    Nomani H, Ghobadloo SM, Yaghmaei B, et al. Glutathione S-transferases activity in patients with colorectal cancer[J]. Clin Biochem 2005; 38: 621–624.CrossRefPubMedGoogle Scholar
  44. [44]
    Prabhu K, Bhat GP. Serum total glutathione-Stransferase levels in oral cancer[J]. J Cancer Res Ther 2007; 3: 167–168.CrossRefPubMedGoogle Scholar
  45. [45]
    Sharma A, Tripathi M, Satyam A, et al. Study of antioxidant levels in patients with multiple myeloma[J]. Leuk Lymphoma 2009; 50: 809–815.CrossRefPubMedGoogle Scholar
  46. [46]
    Ho JC, Chan-Yeung M, Ho SP, et al. Disturbance of systemic antioxidant profile in nonsmall cell lung carcinoma[J]. Eur Respir J 2007; 29: 273–278.CrossRefPubMedGoogle Scholar
  47. [47]
    Monari M, Foschi J, Calabrese C, et al. Implications of antioxidant enzymes in human gastric neoplasms[J]. Int J Mol Med 2009; 24: 693–700.CrossRefPubMedGoogle Scholar
  48. [48]
    Arsova-Sarafinovska Z, Eken A, Matevska N, et al. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer[J]. Clin Biochem 2009; 42: 1228–1235.CrossRefPubMedGoogle Scholar
  49. [49]
    Kotrikadze N, Alibegashvili M, Zibzibadze M, et al. Activity and content of antioxidant enzymes in prostate tumors[J]. Exp Oncol 2008; 30: 244–247.PubMedGoogle Scholar
  50. [50]
    Gokul S, Patil V, Jailkhani R, et al. Oxidantantioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients[J]. Oral Dis 2009; Jul 27 [Epub ahead of print].Google Scholar
  51. [51]
    Rajaraman P, Hutchinson A, Rothman N, et al. Oxidative response gene polymorphisms and risk of adult brain tumors[J]. Neuro Oncol 2008; 10: 709–715.CrossRefPubMedGoogle Scholar
  52. [52]
    Battisti V, Maders LD, Bagatini MD, et al. Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients[J]. Clin Biochem 2008; 41: 511–518.CrossRefPubMedGoogle Scholar
  53. [53]
    Jeon SH, Park JH, Chang SG. Expression of antioxidant enzymes (catalase, superoxide dismutase, and glutathione peroxidase) in human bladder cancer[J]. Korean J Urol 2007; 48: 921–926.CrossRefGoogle Scholar
  54. [54]
    Onumah OE, Jules GE, Zhao Y, et al. Overexpression of catalase delays G0/G1-to S-phase transition during cell cycle progression in mouse aortic endothelial cells[J]. Free Radic Biol Med 2009, 46: 1658–1667.CrossRefPubMedGoogle Scholar
  55. [55]
    Ando T, Mimura K, Johansson CC, et al. Transduction with the antioxidant enzyme catalase protects human t cells against oxidative stress[J]. J Immunol 2008; 181: 8382–8390.PubMedGoogle Scholar
  56. [56]
    Liu J, Hinkhouse MM, Sun W, et al. Redox regulation of pancreatic cancer cell growth: role of glutathione peroxidase in the suppression of the malignant phenotype[J]. Hum Gene Ther 2004; 15: 239–250.CrossRefPubMedGoogle Scholar
  57. [57]
    Yu J, Kim AK. Effect of taurine on antioxidant enzyme system in B16F10 melanoma cells[J]. Adv Exp Med Biol 2009; 643: 491–499.CrossRefPubMedGoogle Scholar
  58. [58]
    Feng X, Zhang L, Zhu H. Comparative anticancer and antioxidant activities of different ingredients of Ginkgo biloba extract (EGb 761)[J]. Planta Med 2009; 75: 792–796.CrossRefPubMedGoogle Scholar

Copyright information

© Chinese Anti-Cancer Association and Springer Berlin Heidelberg 2010

Authors and Affiliations

  • Md. Asaduzzaman Khan
    • 1
  • Mousumi Tania
    • 1
  • Dian-zheng Zhang
    • 1
    • 2
  • Han-chun Chen
    • 1
    Email author
  1. 1.Department of Biochemistry, School of Biological Science and TechnologyCentral South UniversityChangshaChina
  2. 2.Department of Biochemistry/Molecular Biology and Center for Chronic Disorders of AgingPhiladelphia College of Osteopathic MedicinePhiladelphiaUSA

Personalised recommendations